Amgen, Kyowa Kirin partner to develop antibody for atopic dermatitis
Amgen has signed an agreement with Japanese pharmaceutical firm Kyowa Kirin to jointly develop and commercialise Phase III-ready antibody for treating atopic dermatitis. Discovered by Kyowa Kirin, the